Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.
暂无分享,去创建一个
A. Larson | Zhuoli Zhang | Chong Sun | V. Yaghmai | Guoxin Li | D. Procissi | S. Gu | Sijia Wang | Na Shang | Bin Wang | M. Figini | Q. Ma
[1] B. Ruffell,et al. Dendritic Cells and Cancer Immunity. , 2016, Trends in immunology.
[2] C. Figdor,et al. Dendritic Cell–Based Immunotherapy: State of the Art and Beyond , 2016, Clinical Cancer Research.
[3] Ö. Türeci,et al. Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines , 2016, Clinical Cancer Research.
[4] Jordi Llop,et al. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes. , 2016, ACS nano.
[5] L. Yakovleva,et al. 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[6] Hua Ai,et al. Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner. , 2015, Biomaterials.
[7] W. Moon,et al. In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin , 2015, PloS one.
[8] J. Bárcena,et al. In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells. , 2015, Molecular immunology.
[9] B. Czerniecki,et al. Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy , 2014, The Yale journal of biology and medicine.
[10] A. Goyal,et al. Are the anatomical sites for vaccine administration selected judiciously? , 2014, International immunopharmacology.
[11] C. Figdor,et al. Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets , 2014, Front. Immunol..
[12] F. Ginhoux,et al. Organization of the mouse and human DC network. , 2014, Current opinion in immunology.
[13] B. Neyns,et al. A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] E. Gostick,et al. Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration , 2013, Influenza and other respiratory viruses.
[15] N. McGovern,et al. Human dendritic cell subsets , 2013, Immunology.
[16] J. Banchereau,et al. Dendritic-cell-based therapeutic cancer vaccines. , 2013, Immunity.
[17] I. Mellman,et al. Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.
[18] R. Tilley,et al. Using Magnetic Resonance Imaging to Evaluate Dendritic Cell-Based Vaccination , 2013, PloS one.
[19] Carlo Fiorini,et al. In Vivo Imaging of Lymph Node Migration of MNP- and 111In-Labeled Dendritic Cells in a Transgenic Mouse Model of Breast Cancer (MMTV-Ras) , 2012, Molecular Imaging and Biology.
[20] I. M. Belyakov,et al. Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection , 2012, Nature Medicine.
[21] J. Mcghee,et al. Novel vaccine development strategies for inducing mucosal immunity , 2012, Expert review of vaccines.
[22] M. Levings,et al. Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model. , 2011, Cytotherapy.
[23] Baoan Chen,et al. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide , 2011, International journal of nanomedicine.
[24] S. Gambhir,et al. Noninvasive cell-tracking methods , 2011, Nature Reviews Clinical Oncology.
[25] J. Gore,et al. Multimodal imaging of dendritic cells using a novel hybrid magneto-optical nanoprobe. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[26] W. Oyen,et al. Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients , 2011, Clinical Cancer Research.
[27] J. Snir,et al. Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI. , 2011, Contrast media & molecular imaging.
[28] V. Awasthi,et al. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine , 2010, BMC Immunology.
[29] C. Dutertre,et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells , 2010, The Journal of experimental medicine.
[30] Beatriz Pelaz,et al. The effect of static magnetic fields and tat peptides on cellular and nuclear uptake of magnetic nanoparticles. , 2010, Biomaterials.
[31] R. Sékaly,et al. Semiquantitation of Mouse Dendritic Cell Migration In Vivo Using Cellular MRI , 2009, Journal of immunotherapy.
[32] J. Bulte,et al. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. , 2009, Cancer research.
[33] W. Oyen,et al. Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients , 2009, Clinical Cancer Research.
[34] V. Bronte,et al. Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells , 2008, Immunological reviews.
[35] Carl G. Figdor,et al. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting , 2007, Nature Reviews Immunology.
[36] R. Steinman,et al. Taking dendritic cells into medicine , 2007, Nature.
[37] S. Caruthers,et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] Noriaki Okamoto,et al. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. , 2007, The Journal of clinical investigation.
[39] R. Steinman,et al. Dendritic cell–expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice , 2007, The Journal of experimental medicine.
[40] J. Xiang,et al. Intradermal vaccination of dendritic cell-derived exosomes is superior to a subcutaneous one in the induction of antitumor immunity. , 2006, Cancer biotherapy & radiopharmaceuticals.
[41] P. Acton,et al. Imaging reporter genes for cell tracking with PET and SPECT. , 2005, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[42] Mathias Hoehn,et al. Cellular MR Imaging , 2005, Molecular imaging.
[43] A. Devillers,et al. Biodistribution of radiolabelled human dendritic cells injected by various routes , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[44] A. Palucka,et al. Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.
[45] C. Figdor,et al. Migration of dendritic cell based cancer vaccines: in vivo veritas? , 2005, Current opinion in immunology.
[46] Enzo Terreno,et al. Tunable imaging of cells labeled with MRI-PARACEST agents. , 2005, Angewandte Chemie.
[47] Michel C Nussenzweig,et al. Tolerogenic dendritic cells. , 2003, Annual review of immunology.
[48] C. Figdor,et al. Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[49] M. Grégoire,et al. Optimizing dendritic cell–based anticancer immunotherapy: maturation state does have clinical impact , 2003, Cancer Immunology, Immunotherapy.
[50] A. Lew,et al. Antigen targeted to secondary lymphoid organs via vascular cell adhesion molecule (VCAM) enhances an immune response. , 2003, Vaccine.
[51] Ying K. Tam,et al. Cytokines in the generation and maturation of dendritic cells: recent advances. , 2002, European cytokine network.
[52] Michael E. Phelps,et al. Ex vivo cell labeling with 64Cu–pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Lyerly,et al. Dendritic cell maturation in active immunotherapy strategies , 2002, Expert opinion on biological therapy.
[54] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[55] Edgar G. Engleman,et al. Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients1 , 2001, The Journal of Immunology.
[56] W C Eckelman,et al. High resolution PET, SPECT and projection imaging in small animals. , 2001, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[57] A. Mackensen,et al. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells , 1999, Cancer Immunology, Immunotherapy.
[58] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[59] R. Steinman,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.
[60] M. Berkowitz,et al. Differentiation of dendritic cells in cultures of rat bone marrow cells , 1986, The Journal of experimental medicine.
[61] A. Larson,et al. Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model. , 2015, Radiology.
[62] M. Strioga,et al. Therapeutic dendritic cell-based cancer vaccines: the state of the art. , 2013, Critical reviews in immunology.
[63] P. Foster,et al. Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes. , 2012, International immunology.
[64] R. Steinman,et al. Pillars Article: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med.1973. 137: 1142-1162. , 2007, Journal of immunology.
[65] Ira Mellman,et al. Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.
[66] Li Wu,et al. Mouse Plasmacytoid Cells: Long-lived Cells, Heterogeneous in Surface Phenotype and Function, that Differentiate Into CD8 (cid:2) Dendritic Cells Only after Microbial Stimulus , 2002 .
[67] R. Coleman,et al. Migration of human dendritic cells after injection in patients with metastatic malignancies. , 1999, Cancer research.
[68] Edgar G. Engleman,et al. Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.
[69] W. Egner,et al. Isolation and function of human dendritic cells. , 1994, International review of cytology.